Global Peripheral Parenteral Nutrition (PPN) Market Growth (Status and Outlook) 2026-2032
The global Peripheral Parenteral Nutrition (PPN) market size is predicted to grow from US$ 1223 million in 2025 to US$ 1837 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.
Peripheral Parenteral Nutrition (PPN) Solutions are sterile intravenous nutritional formulations administered through peripheral veins to provide short-term or partial nutritional support for patients who cannot fully meet nutritional needs through oral or enteral intake. PPN solutions usually contain amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, and sterile water, but their osmolarity and nutrient concentration are generally lower than central parenteral nutrition formulations. They are mainly used for perioperative nutrition support, temporary feeding interruption, mild to moderate malnutrition, gastrointestinal dysfunction, oncology care, emergency supplementation, and patients who do not require central venous access.The industrial chain of Peripheral Parenteral Nutrition (PPN) Solutions includes upstream amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, sterile water, pharmaceutical packaging materials, multi-chamber bags, infusion ports, aseptic filling materials, sterilization systems, and quality-control reagents. The midstream consists of pharmaceutical manufacturers integrating formulation development, sterile compounding, aseptic filling, bag sealing, sterilization, inspection, labeling, packaging, and batch release into finished PPN solution products. Downstream applications mainly include hospitals, surgical wards, oncology departments, gastroenterology departments, emergency care, outpatient infusion centers, home infusion services, long-term care facilities, and clinical nutrition departments. Related services include prescription adjustment, pharmacy compounding, cold-chain logistics, patient monitoring, training, clinical nutrition support, and adverse-event management.The gross profit margin of major companies in the industry was between 35%–55%.
The Peripheral Parenteral Nutrition (PPN) Solution market is mainly driven by short-term clinical nutrition support, perioperative nutrition management, gastrointestinal dysfunction treatment, oncology care, emergency supplementation, and increasing use of standardized ready-to-use nutrition bags. As hospitals seek safer and more convenient nutrition therapy for patients who do not require central venous access, demand for sterile PPN solutions continues to increase. Compared with TPN, PPN is more suitable for short-duration and lower-concentration nutritional supplementation, making it useful in surgical recovery, temporary feeding interruption, and transitional care. Product development is moving toward safer formulations, better electrolyte balance, improved lipid emulsions, multi-chamber packaging, lower infection risk, and easier clinical preparation. Overall, the market is expected to maintain steady growth, with stronger demand from hospitals, surgical departments, oncology care, and outpatient infusion services.
LPI (LP Information)' newest research report, the “Peripheral Parenteral Nutrition (PPN) Industry Forecast” looks at past sales and reviews total world Peripheral Parenteral Nutrition (PPN) sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Parenteral Nutrition (PPN) sales for 2026 through 2032. With Peripheral Parenteral Nutrition (PPN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Parenteral Nutrition (PPN) industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Parenteral Nutrition (PPN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Parenteral Nutrition (PPN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Parenteral Nutrition (PPN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Parenteral Nutrition (PPN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Parenteral Nutrition (PPN).
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Parenteral Nutrition (PPN) market by product type, application, key players and key regions and countries.
Peripheral Parenteral Nutrition (PPN) Solutions are sterile intravenous nutritional formulations administered through peripheral veins to provide short-term or partial nutritional support for patients who cannot fully meet nutritional needs through oral or enteral intake. PPN solutions usually contain amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, and sterile water, but their osmolarity and nutrient concentration are generally lower than central parenteral nutrition formulations. They are mainly used for perioperative nutrition support, temporary feeding interruption, mild to moderate malnutrition, gastrointestinal dysfunction, oncology care, emergency supplementation, and patients who do not require central venous access.The industrial chain of Peripheral Parenteral Nutrition (PPN) Solutions includes upstream amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, sterile water, pharmaceutical packaging materials, multi-chamber bags, infusion ports, aseptic filling materials, sterilization systems, and quality-control reagents. The midstream consists of pharmaceutical manufacturers integrating formulation development, sterile compounding, aseptic filling, bag sealing, sterilization, inspection, labeling, packaging, and batch release into finished PPN solution products. Downstream applications mainly include hospitals, surgical wards, oncology departments, gastroenterology departments, emergency care, outpatient infusion centers, home infusion services, long-term care facilities, and clinical nutrition departments. Related services include prescription adjustment, pharmacy compounding, cold-chain logistics, patient monitoring, training, clinical nutrition support, and adverse-event management.The gross profit margin of major companies in the industry was between 35%–55%.
The Peripheral Parenteral Nutrition (PPN) Solution market is mainly driven by short-term clinical nutrition support, perioperative nutrition management, gastrointestinal dysfunction treatment, oncology care, emergency supplementation, and increasing use of standardized ready-to-use nutrition bags. As hospitals seek safer and more convenient nutrition therapy for patients who do not require central venous access, demand for sterile PPN solutions continues to increase. Compared with TPN, PPN is more suitable for short-duration and lower-concentration nutritional supplementation, making it useful in surgical recovery, temporary feeding interruption, and transitional care. Product development is moving toward safer formulations, better electrolyte balance, improved lipid emulsions, multi-chamber packaging, lower infection risk, and easier clinical preparation. Overall, the market is expected to maintain steady growth, with stronger demand from hospitals, surgical departments, oncology care, and outpatient infusion services.
LPI (LP Information)' newest research report, the “Peripheral Parenteral Nutrition (PPN) Industry Forecast” looks at past sales and reviews total world Peripheral Parenteral Nutrition (PPN) sales in 2025, providing a comprehensive analysis by region and market sector of projected Peripheral Parenteral Nutrition (PPN) sales for 2026 through 2032. With Peripheral Parenteral Nutrition (PPN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Parenteral Nutrition (PPN) industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Parenteral Nutrition (PPN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peripheral Parenteral Nutrition (PPN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Parenteral Nutrition (PPN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Parenteral Nutrition (PPN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Parenteral Nutrition (PPN).
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Parenteral Nutrition (PPN) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Single-Chamber Component or Premixed PPN Solutions
- Dual-Chamber Ready-to-Use PPN Solutions
- Three-Chamber Ready-to-Use PPN Solutions
Segmentation by Osmotic Pressure Level:
- Low-Osmolarity PPN Solutions: below 600 mOsm/L
- Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
- Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
Segmentation by Combination of Main Nutrients:
- Amino Acid and Glucose PPN Solutions
- Amino Acid, Glucose and Electrolyte PPN Solutions
- Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
- Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
- Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
- Single-Nutrient PN Component Solutions Used for PPN Compounding
Segmentation by Application:
- Hospital
- Home
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fresenius Kabi AG
- B. Braun SE
- Baxter International Inc.
- Otsuka ICU Medical LLC
- Pfizer Inc.
- Otsuka Pharmaceutical Factory, Inc.
- Yoshindo Holdings Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- SSY Group Limited
- Guangdong Otsuka Pharmaceutical Co., Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd.
- JW Life Science Corporation
- Aculife Healthcare Pvt. Ltd.
- Albert David Limited
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Parenteral Nutrition (PPN) Market Size (2021-2032)
2.1.2 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Peripheral Parenteral Nutrition (PPN) by Country/Region (2021, 2025 & 2032)
2.2 Peripheral Parenteral Nutrition (PPN) Segment by Type
2.2.1 Single-Chamber Component or Premixed PPN Solutions
2.2.2 Dual-Chamber Ready-to-Use PPN Solutions
2.2.3 Three-Chamber Ready-to-Use PPN Solutions
2.2.4 Peripheral Parenteral Nutrition (PPN) Market Size by Type
2.2.4.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
2.3 Peripheral Parenteral Nutrition (PPN) Segment by Osmotic Pressure Level
2.3.1 Low-Osmolarity PPN Solutions: below 600 mOsm/L
2.3.2 Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
2.3.3 Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level
2.3.4.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Osmotic Pressure Level (2021 VS 2025 VS 2032)
2.3.4.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2026)
2.4 Peripheral Parenteral Nutrition (PPN) Segment by Combination of Main Nutrients
2.4.1 Amino Acid and Glucose PPN Solutions
2.4.2 Amino Acid, Glucose and Electrolyte PPN Solutions
2.4.3 Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
2.4.4 Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
2.4.5 Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
2.4.6 Single-Nutrient PN Component Solutions Used for PPN Compounding
2.4.7 Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients
2.4.7.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Combination of Main Nutrients (2021 VS 2025 VS 2032)
2.4.7.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2026)
2.5 Peripheral Parenteral Nutrition (PPN) Segment by Application
2.5.1 Hospital
2.5.2 Home
2.5.3 Peripheral Parenteral Nutrition (PPN) Market Size by Application
2.5.3.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
3 PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE BY PLAYER
3.1 Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Player
3.1.1 Global Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player (2021-2026)
3.2 Global Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL PARENTERAL NUTRITION (PPN) BY REGION
4.1 Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026)
4.2 Global Peripheral Parenteral Nutrition (PPN) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.4 APAC Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.5 Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.6 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026)
5.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
5.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026)
6.2 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
6.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) by Region (2021-2026)
8.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
8.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET FORECAST
10.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.1.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.1.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast
10.1.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast
10.1.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast
10.1.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast
10.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast by Country (2027-2032)
10.2.1 United States Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.2 Canada Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.3 Mexico Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.4 Brazil Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.3.1 China Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.2 Japan Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.3 Korea Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.4 Southeast Asia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.5 India Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.6 Australia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast by Country (2027-2032)
10.4.1 Germany Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.2 France Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.3 UK Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.4 Italy Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.5 Russia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.5.1 Egypt Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.2 South Africa Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.3 Israel Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.4 Turkey Market Peripheral Parenteral Nutrition (PPN) Forecast
10.6 Global Peripheral Parenteral Nutrition (PPN) Forecast by Type (2027-2032)
10.7 Global Peripheral Parenteral Nutrition (PPN) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Peripheral Parenteral Nutrition (PPN) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Fresenius Kabi AG
11.1.1 Fresenius Kabi AG Company Information
11.1.2 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product Offered
11.1.3 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Fresenius Kabi AG Main Business Overview
11.1.5 Fresenius Kabi AG Latest Developments
11.2 B. Braun SE
11.2.1 B. Braun SE Company Information
11.2.2 B. Braun SE Peripheral Parenteral Nutrition (PPN) Product Offered
11.2.3 B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 B. Braun SE Main Business Overview
11.2.5 B. Braun SE Latest Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Information
11.3.2 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Baxter International Inc. Main Business Overview
11.3.5 Baxter International Inc. Latest Developments
11.4 Otsuka ICU Medical LLC
11.4.1 Otsuka ICU Medical LLC Company Information
11.4.2 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product Offered
11.4.3 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Otsuka ICU Medical LLC Main Business Overview
11.4.5 Otsuka ICU Medical LLC Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.5.3 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
11.6 Otsuka Pharmaceutical Factory, Inc.
11.6.1 Otsuka Pharmaceutical Factory, Inc. Company Information
11.6.2 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.6.3 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Otsuka Pharmaceutical Factory, Inc. Main Business Overview
11.6.5 Otsuka Pharmaceutical Factory, Inc. Latest Developments
11.7 Yoshindo Holdings Co., Ltd.
11.7.1 Yoshindo Holdings Co., Ltd. Company Information
11.7.2 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.7.3 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Yoshindo Holdings Co., Ltd. Main Business Overview
11.7.5 Yoshindo Holdings Co., Ltd. Latest Developments
11.8 Sichuan Kelun Pharmaceutical Co., Ltd.
11.8.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
11.8.2 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.8.3 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sichuan Kelun Pharmaceutical Co., Ltd. Main Business Overview
11.8.5 Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
11.9 Haisco Pharmaceutical Group Co., Ltd.
11.9.1 Haisco Pharmaceutical Group Co., Ltd. Company Information
11.9.2 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.9.3 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Haisco Pharmaceutical Group Co., Ltd. Main Business Overview
11.9.5 Haisco Pharmaceutical Group Co., Ltd. Latest Developments
11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business Overview
11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
11.11 SSY Group Limited
11.11.1 SSY Group Limited Company Information
11.11.2 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product Offered
11.11.3 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 SSY Group Limited Main Business Overview
11.11.5 SSY Group Limited Latest Developments
11.12 Guangdong Otsuka Pharmaceutical Co., Ltd.
11.12.1 Guangdong Otsuka Pharmaceutical Co., Ltd. Company Information
11.12.2 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.12.3 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guangdong Otsuka Pharmaceutical Co., Ltd. Main Business Overview
11.12.5 Guangdong Otsuka Pharmaceutical Co., Ltd. Latest Developments
11.13 China Resources Double-Crane Pharmaceutical Co., Ltd.
11.13.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
11.13.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.13.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
11.13.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Latest Developments
11.14 JW Life Science Corporation
11.14.1 JW Life Science Corporation Company Information
11.14.2 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product Offered
11.14.3 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 JW Life Science Corporation Main Business Overview
11.14.5 JW Life Science Corporation Latest Developments
11.15 Aculife Healthcare Pvt. Ltd.
11.15.1 Aculife Healthcare Pvt. Ltd. Company Information
11.15.2 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.15.3 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Aculife Healthcare Pvt. Ltd. Main Business Overview
11.15.5 Aculife Healthcare Pvt. Ltd. Latest Developments
11.16 Albert David Limited
11.16.1 Albert David Limited Company Information
11.16.2 Albert David Limited Peripheral Parenteral Nutrition (PPN) Product Offered
11.16.3 Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Albert David Limited Main Business Overview
11.16.5 Albert David Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Parenteral Nutrition (PPN) Market Size (2021-2032)
2.1.2 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Peripheral Parenteral Nutrition (PPN) by Country/Region (2021, 2025 & 2032)
2.2 Peripheral Parenteral Nutrition (PPN) Segment by Type
2.2.1 Single-Chamber Component or Premixed PPN Solutions
2.2.2 Dual-Chamber Ready-to-Use PPN Solutions
2.2.3 Three-Chamber Ready-to-Use PPN Solutions
2.2.4 Peripheral Parenteral Nutrition (PPN) Market Size by Type
2.2.4.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
2.3 Peripheral Parenteral Nutrition (PPN) Segment by Osmotic Pressure Level
2.3.1 Low-Osmolarity PPN Solutions: below 600 mOsm/L
2.3.2 Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
2.3.3 Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level
2.3.4.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Osmotic Pressure Level (2021 VS 2025 VS 2032)
2.3.4.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2026)
2.4 Peripheral Parenteral Nutrition (PPN) Segment by Combination of Main Nutrients
2.4.1 Amino Acid and Glucose PPN Solutions
2.4.2 Amino Acid, Glucose and Electrolyte PPN Solutions
2.4.3 Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
2.4.4 Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
2.4.5 Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
2.4.6 Single-Nutrient PN Component Solutions Used for PPN Compounding
2.4.7 Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients
2.4.7.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Combination of Main Nutrients (2021 VS 2025 VS 2032)
2.4.7.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2026)
2.5 Peripheral Parenteral Nutrition (PPN) Segment by Application
2.5.1 Hospital
2.5.2 Home
2.5.3 Peripheral Parenteral Nutrition (PPN) Market Size by Application
2.5.3.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
3 PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET SIZE BY PLAYER
3.1 Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Player
3.1.1 Global Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player (2021-2026)
3.2 Global Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL PARENTERAL NUTRITION (PPN) BY REGION
4.1 Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026)
4.2 Global Peripheral Parenteral Nutrition (PPN) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.4 APAC Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.5 Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
4.6 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026)
5.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
5.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026)
6.2 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
6.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) by Region (2021-2026)
8.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
8.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL PARENTERAL NUTRITION (PPN) MARKET FORECAST
10.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.1.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.1.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast
10.1.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast
10.1.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast
10.1.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast
10.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast by Country (2027-2032)
10.2.1 United States Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.2 Canada Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.3 Mexico Market Peripheral Parenteral Nutrition (PPN) Forecast
10.2.4 Brazil Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.3.1 China Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.2 Japan Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.3 Korea Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.4 Southeast Asia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.5 India Market Peripheral Parenteral Nutrition (PPN) Forecast
10.3.6 Australia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast by Country (2027-2032)
10.4.1 Germany Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.2 France Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.3 UK Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.4 Italy Market Peripheral Parenteral Nutrition (PPN) Forecast
10.4.5 Russia Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast by Region (2027-2032)
10.5.1 Egypt Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.2 South Africa Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.3 Israel Market Peripheral Parenteral Nutrition (PPN) Forecast
10.5.4 Turkey Market Peripheral Parenteral Nutrition (PPN) Forecast
10.6 Global Peripheral Parenteral Nutrition (PPN) Forecast by Type (2027-2032)
10.7 Global Peripheral Parenteral Nutrition (PPN) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Peripheral Parenteral Nutrition (PPN) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Fresenius Kabi AG
11.1.1 Fresenius Kabi AG Company Information
11.1.2 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product Offered
11.1.3 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Fresenius Kabi AG Main Business Overview
11.1.5 Fresenius Kabi AG Latest Developments
11.2 B. Braun SE
11.2.1 B. Braun SE Company Information
11.2.2 B. Braun SE Peripheral Parenteral Nutrition (PPN) Product Offered
11.2.3 B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 B. Braun SE Main Business Overview
11.2.5 B. Braun SE Latest Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Information
11.3.2 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Baxter International Inc. Main Business Overview
11.3.5 Baxter International Inc. Latest Developments
11.4 Otsuka ICU Medical LLC
11.4.1 Otsuka ICU Medical LLC Company Information
11.4.2 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product Offered
11.4.3 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Otsuka ICU Medical LLC Main Business Overview
11.4.5 Otsuka ICU Medical LLC Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.5.3 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
11.6 Otsuka Pharmaceutical Factory, Inc.
11.6.1 Otsuka Pharmaceutical Factory, Inc. Company Information
11.6.2 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.6.3 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Otsuka Pharmaceutical Factory, Inc. Main Business Overview
11.6.5 Otsuka Pharmaceutical Factory, Inc. Latest Developments
11.7 Yoshindo Holdings Co., Ltd.
11.7.1 Yoshindo Holdings Co., Ltd. Company Information
11.7.2 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.7.3 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Yoshindo Holdings Co., Ltd. Main Business Overview
11.7.5 Yoshindo Holdings Co., Ltd. Latest Developments
11.8 Sichuan Kelun Pharmaceutical Co., Ltd.
11.8.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
11.8.2 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.8.3 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sichuan Kelun Pharmaceutical Co., Ltd. Main Business Overview
11.8.5 Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
11.9 Haisco Pharmaceutical Group Co., Ltd.
11.9.1 Haisco Pharmaceutical Group Co., Ltd. Company Information
11.9.2 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.9.3 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Haisco Pharmaceutical Group Co., Ltd. Main Business Overview
11.9.5 Haisco Pharmaceutical Group Co., Ltd. Latest Developments
11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business Overview
11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
11.11 SSY Group Limited
11.11.1 SSY Group Limited Company Information
11.11.2 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product Offered
11.11.3 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 SSY Group Limited Main Business Overview
11.11.5 SSY Group Limited Latest Developments
11.12 Guangdong Otsuka Pharmaceutical Co., Ltd.
11.12.1 Guangdong Otsuka Pharmaceutical Co., Ltd. Company Information
11.12.2 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.12.3 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guangdong Otsuka Pharmaceutical Co., Ltd. Main Business Overview
11.12.5 Guangdong Otsuka Pharmaceutical Co., Ltd. Latest Developments
11.13 China Resources Double-Crane Pharmaceutical Co., Ltd.
11.13.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
11.13.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.13.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
11.13.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Latest Developments
11.14 JW Life Science Corporation
11.14.1 JW Life Science Corporation Company Information
11.14.2 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product Offered
11.14.3 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 JW Life Science Corporation Main Business Overview
11.14.5 JW Life Science Corporation Latest Developments
11.15 Aculife Healthcare Pvt. Ltd.
11.15.1 Aculife Healthcare Pvt. Ltd. Company Information
11.15.2 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
11.15.3 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Aculife Healthcare Pvt. Ltd. Main Business Overview
11.15.5 Aculife Healthcare Pvt. Ltd. Latest Developments
11.16 Albert David Limited
11.16.1 Albert David Limited Company Information
11.16.2 Albert David Limited Peripheral Parenteral Nutrition (PPN) Product Offered
11.16.3 Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Albert David Limited Main Business Overview
11.16.5 Albert David Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Peripheral Parenteral Nutrition (PPN) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-Chamber Component or Premixed PPN Solutions
Table 4. Major Players of Dual-Chamber Ready-to-Use PPN Solutions
Table 5. Major Players of Three-Chamber Ready-to-Use PPN Solutions
Table 6. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Low-Osmolarity PPN Solutions: below 600 mOsm/L
Table 10. Major Players of Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
Table 11. Major Players of Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
Table 12. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Osmotic Pressure Level (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2021-2026) & ($ millions)
Table 14. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2026)
Table 15. Major Players of Amino Acid and Glucose PPN Solutions
Table 16. Major Players of Amino Acid, Glucose and Electrolyte PPN Solutions
Table 17. Major Players of Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
Table 18. Major Players of Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
Table 19. Major Players of Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
Table 20. Major Players of Single-Nutrient PN Component Solutions Used for PPN Compounding
Table 21. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Combination of Main Nutrients (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2021-2026) & ($ millions)
Table 23. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2026)
Table 24. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player (2021-2026)
Table 29. Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
Table 30. Peripheral Parenteral Nutrition (PPN) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Table 35. Global Peripheral Parenteral Nutrition (PPN) Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2021-2026)
Table 39. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Table 41. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Table 43. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Table 45. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2021-2026)
Table 49. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Peripheral Parenteral Nutrition (PPN)
Table 55. Key Market Challenges & Risks of Peripheral Parenteral Nutrition (PPN)
Table 56. Key Industry Trends of Peripheral Parenteral Nutrition (PPN)
Table 57. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Fresenius Kabi AG Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 62. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product Offered
Table 63. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Fresenius Kabi AG Main Business
Table 65. Fresenius Kabi AG Latest Developments
Table 66. B. Braun SE Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 67. B. Braun SE Peripheral Parenteral Nutrition (PPN) Product Offered
Table 68. B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. B. Braun SE Main Business
Table 70. B. Braun SE Latest Developments
Table 71. Baxter International Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 72. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 73. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Baxter International Inc. Main Business
Table 75. Baxter International Inc. Latest Developments
Table 76. Otsuka ICU Medical LLC Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 77. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product Offered
Table 78. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Otsuka ICU Medical LLC Main Business
Table 80. Otsuka ICU Medical LLC Latest Developments
Table 81. Pfizer Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 82. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 83. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Pfizer Inc. Main Business
Table 85. Pfizer Inc. Latest Developments
Table 86. Otsuka Pharmaceutical Factory, Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 87. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 88. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Otsuka Pharmaceutical Factory, Inc. Main Business
Table 90. Otsuka Pharmaceutical Factory, Inc. Latest Developments
Table 91. Yoshindo Holdings Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 92. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 93. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Yoshindo Holdings Co., Ltd. Main Business
Table 95. Yoshindo Holdings Co., Ltd. Latest Developments
Table 96. Sichuan Kelun Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 97. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 98. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Sichuan Kelun Pharmaceutical Co., Ltd. Main Business
Table 100. Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
Table 101. Haisco Pharmaceutical Group Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 102. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 103. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Haisco Pharmaceutical Group Co., Ltd. Main Business
Table 105. Haisco Pharmaceutical Group Co., Ltd. Latest Developments
Table 106. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 108. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business
Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
Table 111. SSY Group Limited Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 112. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product Offered
Table 113. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. SSY Group Limited Main Business
Table 115. SSY Group Limited Latest Developments
Table 116. Guangdong Otsuka Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 117. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 118. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Guangdong Otsuka Pharmaceutical Co., Ltd. Main Business
Table 120. Guangdong Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 121. China Resources Double-Crane Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 122. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 123. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. China Resources Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 125. China Resources Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 126. JW Life Science Corporation Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 127. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product Offered
Table 128. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. JW Life Science Corporation Main Business
Table 130. JW Life Science Corporation Latest Developments
Table 131. Aculife Healthcare Pvt. Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 132. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 133. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Aculife Healthcare Pvt. Ltd. Main Business
Table 135. Aculife Healthcare Pvt. Ltd. Latest Developments
Table 136. Albert David Limited Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 137. Albert David Limited Peripheral Parenteral Nutrition (PPN) Product Offered
Table 138. Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Albert David Limited Main Business
Table 140. Albert David Limited Latest Developments
Table 1. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Peripheral Parenteral Nutrition (PPN) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-Chamber Component or Premixed PPN Solutions
Table 4. Major Players of Dual-Chamber Ready-to-Use PPN Solutions
Table 5. Major Players of Three-Chamber Ready-to-Use PPN Solutions
Table 6. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Low-Osmolarity PPN Solutions: below 600 mOsm/L
Table 10. Major Players of Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
Table 11. Major Players of Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
Table 12. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Osmotic Pressure Level (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2021-2026) & ($ millions)
Table 14. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2026)
Table 15. Major Players of Amino Acid and Glucose PPN Solutions
Table 16. Major Players of Amino Acid, Glucose and Electrolyte PPN Solutions
Table 17. Major Players of Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
Table 18. Major Players of Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
Table 19. Major Players of Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
Table 20. Major Players of Single-Nutrient PN Component Solutions Used for PPN Compounding
Table 21. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Combination of Main Nutrients (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2021-2026) & ($ millions)
Table 23. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2026)
Table 24. Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player (2021-2026)
Table 29. Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
Table 30. Peripheral Parenteral Nutrition (PPN) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Table 35. Global Peripheral Parenteral Nutrition (PPN) Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2021-2026)
Table 39. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Table 41. Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Table 43. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Table 45. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country (2021-2026)
Table 49. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Peripheral Parenteral Nutrition (PPN)
Table 55. Key Market Challenges & Risks of Peripheral Parenteral Nutrition (PPN)
Table 56. Key Industry Trends of Peripheral Parenteral Nutrition (PPN)
Table 57. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Peripheral Parenteral Nutrition (PPN) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Fresenius Kabi AG Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 62. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product Offered
Table 63. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Fresenius Kabi AG Main Business
Table 65. Fresenius Kabi AG Latest Developments
Table 66. B. Braun SE Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 67. B. Braun SE Peripheral Parenteral Nutrition (PPN) Product Offered
Table 68. B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. B. Braun SE Main Business
Table 70. B. Braun SE Latest Developments
Table 71. Baxter International Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 72. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 73. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Baxter International Inc. Main Business
Table 75. Baxter International Inc. Latest Developments
Table 76. Otsuka ICU Medical LLC Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 77. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product Offered
Table 78. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Otsuka ICU Medical LLC Main Business
Table 80. Otsuka ICU Medical LLC Latest Developments
Table 81. Pfizer Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 82. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 83. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Pfizer Inc. Main Business
Table 85. Pfizer Inc. Latest Developments
Table 86. Otsuka Pharmaceutical Factory, Inc. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 87. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 88. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Otsuka Pharmaceutical Factory, Inc. Main Business
Table 90. Otsuka Pharmaceutical Factory, Inc. Latest Developments
Table 91. Yoshindo Holdings Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 92. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 93. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Yoshindo Holdings Co., Ltd. Main Business
Table 95. Yoshindo Holdings Co., Ltd. Latest Developments
Table 96. Sichuan Kelun Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 97. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 98. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Sichuan Kelun Pharmaceutical Co., Ltd. Main Business
Table 100. Sichuan Kelun Pharmaceutical Co., Ltd. Latest Developments
Table 101. Haisco Pharmaceutical Group Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 102. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 103. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Haisco Pharmaceutical Group Co., Ltd. Main Business
Table 105. Haisco Pharmaceutical Group Co., Ltd. Latest Developments
Table 106. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 108. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Main Business
Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Latest Developments
Table 111. SSY Group Limited Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 112. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product Offered
Table 113. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. SSY Group Limited Main Business
Table 115. SSY Group Limited Latest Developments
Table 116. Guangdong Otsuka Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 117. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 118. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Guangdong Otsuka Pharmaceutical Co., Ltd. Main Business
Table 120. Guangdong Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 121. China Resources Double-Crane Pharmaceutical Co., Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 122. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 123. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. China Resources Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 125. China Resources Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 126. JW Life Science Corporation Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 127. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product Offered
Table 128. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. JW Life Science Corporation Main Business
Table 130. JW Life Science Corporation Latest Developments
Table 131. Aculife Healthcare Pvt. Ltd. Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 132. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product Offered
Table 133. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Aculife Healthcare Pvt. Ltd. Main Business
Table 135. Aculife Healthcare Pvt. Ltd. Latest Developments
Table 136. Albert David Limited Details, Company Type, Peripheral Parenteral Nutrition (PPN) Area Served and Its Competitors
Table 137. Albert David Limited Peripheral Parenteral Nutrition (PPN) Product Offered
Table 138. Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Albert David Limited Main Business
Table 140. Albert David Limited Latest Developments
LIST OF FIGURES
Figure 1. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Peripheral Parenteral Nutrition (PPN) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2025)
Figure 8. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2025
Figure 10. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level in 2025
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients in 2025
Figure 12. Peripheral Parenteral Nutrition (PPN) in Hospital
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market: Hospital (2021-2026) & ($ millions)
Figure 14. Peripheral Parenteral Nutrition (PPN) in Home
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market: Home (2021-2026) & ($ millions)
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2025
Figure 17. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player in 2025
Figure 18. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 20. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 23. Americas Peripheral Parenteral Nutrition (PPN) Value Market Share by Country in 2025
Figure 24. United States Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region in 2025
Figure 29. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 31. China Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country in 2025
Figure 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 54. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 55. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 57. United States Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 58. Canada Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 61. China Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 62. Japan Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 63. Korea Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 65. India Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 66. Australia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 67. Germany Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 68. France Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 69. UK Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 70. Italy Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 71. Russia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 74. Israel Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 76. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 1. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Peripheral Parenteral Nutrition (PPN) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2025)
Figure 8. Peripheral Parenteral Nutrition (PPN) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2025
Figure 10. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level in 2025
Figure 11. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients in 2025
Figure 12. Peripheral Parenteral Nutrition (PPN) in Hospital
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market: Hospital (2021-2026) & ($ millions)
Figure 14. Peripheral Parenteral Nutrition (PPN) in Home
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market: Home (2021-2026) & ($ millions)
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2025
Figure 17. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Player in 2025
Figure 18. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 20. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 21. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2021-2026 ($ millions)
Figure 23. Americas Peripheral Parenteral Nutrition (PPN) Value Market Share by Country in 2025
Figure 24. United States Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region in 2025
Figure 29. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 31. China Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Country in 2025
Figure 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Peripheral Parenteral Nutrition (PPN) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 54. APAC Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 55. Europe Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 57. United States Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 58. Canada Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 61. China Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 62. Japan Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 63. Korea Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 65. India Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 66. Australia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 67. Germany Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 68. France Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 69. UK Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 70. Italy Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 71. Russia Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 74. Israel Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
Figure 76. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Peripheral Parenteral Nutrition (PPN) Market Size 2027-2032 ($ millions)
More Publications
Global Pets Vitamins and Supplements Market Growth 2023-2029
US$ 3,660.00
March 2023
112 pages
Global Pharmaceutical Borosilicate Glass Tubes Market Growth 2023-2029
US$ 3,660.00
March 2023
116 pages
Global Amniotic Products Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
123 pages
Global Vaccine for Influenza Market Growth 2025-2031
US$ 3,660.00
April 2025
106 pages
Global Medical Holographic Displays Market Growth 2023-2029
US$ 3,660.00
February 2023
100 pages
